Astec LifeSciences Bilan de santé
Santé financière contrôle des critères 1/6
Astec LifeSciences possède un total de capitaux propres de ₹2.9B et une dette totale de ₹5.0B, ce qui porte son ratio d'endettement à 171.5%. Son actif total et son passif total sont ₹8.8B et de ₹5.9B.
Informations clés
171.5%
Ratio d'endettement
₹5.00b
Dette
| Ratio de couverture des intérêts | n/a |
| Argent liquide | ₹20.68m |
| Fonds propres | ₹2.92b |
| Total du passif | ₹5.90b |
| Total des actifs | ₹8.82b |
Mises à jour récentes de la santé financière
Here's Why Astec LifeSciences (NSE:ASTEC) Can Manage Its Debt Responsibly
Jun 28
Is Astec LifeSciences (NSE:ASTEC) A Risky Investment?
Dec 13Does Astec LifeSciences (NSE:ASTEC) Have A Healthy Balance Sheet?
May 02Recent updates
Shareholders May Be Wary Of Increasing Astec LifeSciences Limited's (NSE:ASTEC) CEO Compensation Package
Jul 23Market Participants Recognise Astec LifeSciences Limited's (NSE:ASTEC) Revenues Pushing Shares 28% Higher
Jul 03Astec LifeSciences Limited (NSE:ASTEC) Stocks Shoot Up 30% But Its P/S Still Looks Reasonable
Mar 15Astec LifeSciences (NSE:ASTEC) Could Be Struggling To Allocate Capital
May 17Shareholders Are Optimistic That Astec LifeSciences (NSE:ASTEC) Will Multiply In Value
Oct 14We Ran A Stock Scan For Earnings Growth And Astec LifeSciences (NSE:ASTEC) Passed With Ease
Jul 27Here's Why Astec LifeSciences (NSE:ASTEC) Can Manage Its Debt Responsibly
Jun 28A Look At The Intrinsic Value Of Astec LifeSciences Limited (NSE:ASTEC)
Jun 03Analysts Just Published A Bright New Outlook For Astec LifeSciences Limited's (NSE:ASTEC)
May 08Astec LifeSciences Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
May 06Why We Like The Returns At Astec LifeSciences (NSE:ASTEC)
Jan 25Is Astec LifeSciences (NSE:ASTEC) A Risky Investment?
Dec 13We Take A Look At Why Astec LifeSciences Limited's (NSE:ASTEC) CEO Has Earned Their Pay Packet
Jul 21Does Astec LifeSciences (NSE:ASTEC) Have A Healthy Balance Sheet?
May 02The Trend Of High Returns At Astec LifeSciences (NSE:ASTEC) Has Us Very Interested
Apr 17Do Astec LifeSciences's (NSE:ASTEC) Earnings Warrant Your Attention?
Apr 02Is Astec LifeSciences Limited's (NSE:ASTEC) Shareholder Ownership Skewed Towards Insiders?
Mar 18Have Insiders Been Selling Astec LifeSciences Limited (NSE:ASTEC) Shares?
Mar 05Did You Miss Astec LifeSciences' (NSE:ASTEC) Whopping 481% Share Price Gain?
Feb 20A Look At Astec LifeSciences' (NSE:ASTEC) CEO Remuneration
Feb 08Declining Stock and Solid Fundamentals: Is The Market Wrong About Astec LifeSciences Limited (NSE:ASTEC)?
Jan 28What Does Astec LifeSciences Limited's (NSE:ASTEC) Share Price Indicate?
Jan 17
Why We Like The Returns At Astec LifeSciences (NSE:ASTEC)
Jan 08I Ran A Stock Scan For Earnings Growth And Astec LifeSciences (NSE:ASTEC) Passed With Ease
Dec 28Is Astec LifeSciences Limited (NSE:ASTEC) Popular Amongst Insiders?
Dec 18Astec LifeSciences (NSE:ASTEC) Is Growing Earnings But Are They A Good Guide?
Dec 07Analyse de la situation financière
Passif à court terme: Les actifs à court terme de ASTEC ( ₹3.0B ) ne couvrent pas ses passifs à court terme ( ₹3.7B ).
Passif à long terme: Les actifs à court terme de ASTEC ( ₹3.0B ) dépassent ses passifs à long terme ( ₹2.2B ).
Historique et analyse du ratio d'endettement
Niveau d'endettement: Le ratio dette nette/capitaux propres de ASTEC ( 170.8% ) est considéré comme élevé.
Réduire la dette: Le ratio d'endettement de ASTEC est passé de 102.5% à 171.5% au cours des 5 dernières années.
Couverture de la dette: La dette de ASTEC n'est pas bien couverte par le flux de trésorerie opérationnel ( 2.4% ).
Couverture des intérêts: Données insuffisantes pour déterminer si les paiements d'intérêts de ASTEC sur sa dette sont bien couverts par l'EBIT.